Qualitek Labs (QLL) | Stock Overview & Key Data
Qualitek Labs Performance Comparison
Stock Range
Today's Range
Low: ₹374.55
High: ₹378.00
on October 7, 2025
52 Week Range
Low: ₹215.05
High: ₹458.95
on March 5, 2025
on September 19, 2025
All-Time High: ₹458.95 on September 19, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR4.6B
EPS
7.10
P/E Ratio (TTM)
58.45
Forward P/E
N/A
P/B Ratio
4.77
PEG Ratio
N/A
Div. Yield
N/A
ROE
12.27%
Beta
N/A
Debt to Equity
37.74
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
20.77%
Profit Margin
8.97%
Returns and Earnings
Return on Assets (TTM)
7.21%
Return on Equity (TTM)
12.27%
EBITDA
INR170.9M
Net Income (TTM)
INR63.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR70.37
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Qualitek Labs QLL | 4.59B Small-cap | -6.13% | -0.44% | 29.09% | 59.68% | 7.47% | 22.74% | 154.68% | 154.68% |
| Dr. Lal PathLabs LALPATHLAB | 270.56B Large-cap | 1.49% | -0.48% | 11.38% | 29.09% | 4.15% | -9.31% | 33.74% | 53.87% |
| Syngene SYNGENE | 254.88B Large-cap | 3.29% | -2.31% | -0.12% | -8.98% | -27.84% | -27.89% | 15.20% | 14.34% |
| Vimta Labs VIMTALABS | 34.69B Small-cap | 6.62% | -11.13% | 60.60% | 71.29% | 49.85% | 165.46% | 322.57% | 959.87% |
| Krsnaa Diagnostics KRSNAA | 25.27B Small-cap | 1.05% | -6.11% | 5.04% | 6.53% | -14.59% | -7.92% | 61.54% | -16.08% |
| Suraksha Diagnostic SURAKSHA | 15.72B Small-cap | 1.11% | -0.76% | -6.58% | 12.85% | -20.61% | -27.68% | -27.68% | -27.68% |
Ownership & Short Interest
Insider Ownership
59.33%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
10K
Average 90-Day Volume
11K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is QLL's 52-week high and low?
- In the last 52 weeks, Qualitek Labs reached a high of ₹458.95 (on September 19, 2025) and a low of ₹215.05 (on March 5, 2025).
- What is the market cap and P/E ratio for QLL?
- Curious about Qualitek Labs's size and valuation? Its market capitalization stands at 4.59B. When it comes to valuation, the P/E ratio (trailing twelve months) is 58.45, and the forward P/E (looking ahead) is N/A.
- Does QLL pay dividends? If so, what's the yield?
- As for dividends, Qualitek Labs isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Qualitek Labs's main competitors or similar companies to consider before investing?
When looking at Qualitek Labs, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Dr. Lal PathLabs
LALPATHLAB270.56B Healthcare Diagnostics & Research -9.31% 33.74% Syngene
SYNGENE254.88B Healthcare Diagnostics & Research -27.89% 15.20% Vimta Labs
VIMTALABS34.69B Healthcare Diagnostics & Research 165.46% 322.57% Krsnaa Diagnostics
KRSNAA25.27B Healthcare Diagnostics & Research -7.92% 61.54% Suraksha Diagnostic
SURAKSHA15.72B Healthcare Diagnostics & Research -27.68% -27.68% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Qualitek Labs Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Qualitek Labs's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.27%, the Debt to Equity ratio from the most recent quarter is 37.74, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for QLL?
- Looking at Qualitek Labs's growth, its revenue over the trailing twelve months (TTM) was INR702M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of QLL stock is held by insiders and institutions?
- Wondering who owns Qualitek Labs stock? Company insiders (like executives and directors) hold about 59.33% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.